Clinical Trial Update: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer [Phase 2]

View source ↗

Summary

This notice describes a Phase 2 trial evaluating the combination of TQB2450 and Anlotinib hydrochloride capsule in advanced endometrial cancer, with the study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Anlotinib hydrochloride capsule (Anlotinib hydrochloride)
• TQB2450

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Advanced Endometrial Cancer | Phase 2 | Status: COMPLETED